{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:10:53Z","timestamp":1784549453697,"version":"3.55.0"},"reference-count":35,"publisher":"BMJ","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"published-print":{"date-parts":[[2013,9,1]]},"DOI":"10.1136\/jnnp-2012-303608","type":"journal-article","created":{"date-parts":[[2013,5,19]],"date-time":"2013-05-19T00:25:11Z","timestamp":1368923111000},"page":"1014-1019","source":"Crossref","is-referenced-by-count":51,"title":["Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia"],"prefix":"10.1136","volume":"84","author":[{"given":"D.","family":"Dressler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Paus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Seitzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Gebhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kupsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ceballos-Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Dengler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ebke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hagenah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Haslinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Heide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hellwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kupsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Paus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Schiefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Storch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vieregge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Volkmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Woldag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2013,5,18]]},"reference":[{"key":"key-10.1136\/jnnp-2012-303608-1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/mds.870060206","article-title":"Idiopathic cervical dystonia: clinical characteristics","volume":"6","author":"Chan","year":"1991","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2012-303608-2","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1212\/01.WNL.0000163767.99354.C3","article-title":"A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia","volume":"64","author":"Benecke","year":"2005","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2012-303608-3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jns.2011.05.041","article-title":"Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN\u00ae, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia","volume":"308","author":"Comella","year":"2011","journal-title":"J Neurol Sci"},{"key":"key-10.1136\/jnnp-2012-303608-4","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1212\/WNL.40.8.1213","article-title":"Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis","volume":"40","author":"Greene","year":"1990","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2012-303608-5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1212\/WNL.49.3.701","article-title":"Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia","volume":"49","author":"Lew","year":"1997","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2012-303608-6","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/mds.20403","article-title":"Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study","volume":"20","author":"Truong","year":"2005","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2012-303608-7","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/mds.22157","article-title":"Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay","volume":"23","author":"Brin","year":"2008","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2012-303608-8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1468-1331.2010.03042.x","article-title":"EFNS guidelines on diagnosis and treatment of primary dystonias","volume":"18","author":"Albanese","year":"2011","journal-title":"Eur J Neurol"},{"key":"key-10.1136\/jnnp-2012-303608-9","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1212\/01.wnl.0000311389.26145.95","article-title":"Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology","volume":"70","author":"Simpson","year":"2008","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2012-303608-10","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1128\/IAI.64.5.1589-1594.1996","article-title":"Molecular composition of Clostridium botulinum type A progenitor toxins","volume":"64","author":"Inoue","year":"1996","journal-title":"Infect Immun"},{"key":"key-10.1136\/jnnp-2012-303608-11","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.toxicon.2009.03.010","article-title":"Xeomin is free from complexing proteins","volume":"54","author":"Frevert","year":"2009","journal-title":"Toxicon"},{"key":"key-10.1136\/jnnp-2012-303608-12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1504\/TBJ.2011.041815","article-title":"Stability of botulinum neurotoxin type A, devoid of complexing proteins","volume":"2","author":"Grein","year":"2011","journal-title":"The Botulinum J"},{"key":"key-10.1136\/jnnp-2012-303608-13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00003495-200767050-00003","article-title":"Botulinum neurotoxin type A free of complexing proteins (XEOMIN\u00ae) in focal dystonia","volume":"67","author":"Jost","year":"2007","journal-title":"Drugs"},{"key":"key-10.1136\/jnnp-2012-303608-14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00702-005-0323-3","article-title":"Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm","volume":"113","author":"Roggenk\u00e4mper","year":"2006","journal-title":"J Neural Transm"},{"key":"key-10.1136\/jnnp-2012-303608-15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00702-010-0529-x","article-title":"Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm","volume":"118","author":"Wabbels","year":"2011","journal-title":"J Neural Transm"},{"issue":"Suppl 4","key":"key-10.1136\/jnnp-2012-303608-16","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1111\/j.1524-4725.2010.01706.x","article-title":"Noninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines","volume":"36","author":"Sattler","year":"2010","journal-title":"Dermatol Surg"},{"issue":"Suppl 4","key":"key-10.1136\/jnnp-2012-303608-17","first-page":"PA540","article-title":"Efficacy and safety of repeated incobotulinumtoxinA injections in subjects with cervical dystonia previously treated with botulinum toxin [abstract]","volume":"76","author":"Evidente","year":"2011","journal-title":"Neurology"},{"issue":"Suppl 4","key":"key-10.1136\/jnnp-2012-303608-18","first-page":"PA330","article-title":"Efficacy and safety of repeated incobotulinumtoxinA injections in subjects with cervical dystonia previously naive to botulinum toxin treatment [abstract]","volume":"76","author":"Fernandez","year":"2011","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2012-303608-19","unstructured":"Interdisziplin\u00e4rer Arbeitskreis Bewegungsst\u00f6rungen. The Dystonia Discomfort Scale (DDS). http:\/\/dds.iabnetz.de (accessed 9 Jan 2012)."},{"key":"key-10.1136\/jnnp-2012-303608-20","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1212\/WNL.42.7.1307","article-title":"Dysphagia after botulinum toxin injections for spasmodic torticollis: clinical and radiologic findings","volume":"42","author":"Comella","year":"1992","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2012-303608-21","first-page":"211","article-title":"Clinical assessments of patients with cervical dystonia","volume-title":"Therapy with botulinum toxin","author":"Consky","year":"1994"},{"key":"key-10.1136\/jnnp-2012-303608-22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0885-3924(00)00146-9","article-title":"Management of spasticity associated pain with botulinum toxin A","volume":"20","author":"Wissel","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"key-10.1136\/jnnp-2012-303608-23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000052139","article-title":"Botulinum toxin antibody testing: comparison between the immunoprecipitation assay and the mouse diaphragm assay","volume":"45","author":"Dressler","year":"2001","journal-title":"Eur Neurol"},{"issue":"Suppl 8","key":"key-10.1136\/jnnp-2012-303608-24","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1002\/mds.20021","article-title":"Detection of antibodies against botulinum toxins","volume":"19","author":"Sesardic","year":"2004","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2012-303608-25","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3109\/00207451003668408","article-title":"RimabotulinumtoxinB effects on pain associated with cervical dystonia: results of placebo and comparator-controlled studies","volume":"120","author":"Lew","year":"2010","journal-title":"Int J Neurosci"},{"key":"key-10.1136\/jnnp-2012-303608-26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1212\/WNL.40.2.277","article-title":"Botulinum toxin injections for cervical dystonia","volume":"40","author":"Jankovic","year":"1990","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2012-303608-27","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1179\/174313209X405137","article-title":"A long-term follow-up of botulinum toxin A in cervical dystonia","volume":"31","author":"Mohammadi","year":"2009","journal-title":"Neurol Res"},{"issue":"Suppl 2","key":"key-10.1136\/jnnp-2012-303608-28","first-page":"PS211","article-title":"IncobotulinumtoxinA (NT-201) injections are safe and effective in adult subjects with cervical dystonia across dosing intervals in a repeated-dose study [abstract]","volume":"26","author":"Truong","year":"2011","journal-title":"Mov Disord"},{"key":"key-10.1136\/jnnp-2012-303608-29","unstructured":"Allergan, Inc. Botox\u00ae US Prescribing Information. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/103000s5232lbl.pdf (accessed 18 Jun 2012)."},{"key":"key-10.1136\/jnnp-2012-303608-30","unstructured":"Ipsen Biopharm, Ltd. Dysport US Prescribing Information. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/125274s0052lbl.pdf (accessed 19 Jun 2012)."},{"key":"key-10.1136\/jnnp-2012-303608-31","unstructured":"Merz Pharmaceuticals GmbH. Xeomin\u00ae US Prescribing Information. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/125360s007lbl.pdf (accessed 19 Jun 2012)."},{"key":"key-10.1136\/jnnp-2012-303608-32","unstructured":"Solstice Neurosciences, Inc. Myobloc US Prescribing Information. 2009."},{"issue":"Suppl 1","key":"key-10.1136\/jnnp-2012-303608-33","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1468-1331.2010.03058.x","article-title":"Botulinum toxin for treatment of dystonia","volume":"17","author":"Dressler","year":"2010","journal-title":"Eur J Neurol"},{"key":"key-10.1136\/jnnp-2012-303608-34","first-page":"PA88","article-title":"Safety and efficacy of repeated NT 201 (Botulinum neurotoxin type A free from complexing proteins) injections of patients with cervical dystonia: a first long-term safety analysis [abstract]","volume":"74","author":"Grafe","year":"2010","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2012-303608-35","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2340\/16501977-0796","article-title":"Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity","volume":"43","author":"Ka\u00f1ovsk\u00fd","year":"2011","journal-title":"J Rehabil Med"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2012-303608","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T17:50:08Z","timestamp":1601056208000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2012-303608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,18]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,8,6]]},"published-print":{"date-parts":[[2013,9,1]]}},"URL":"https:\/\/doi.org\/10.1136\/jnnp-2012-303608","relation":{},"ISSN":["0022-3050"],"issn-type":[{"value":"0022-3050","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5,18]]}}}